ATE456365T1 - Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente - Google Patents

Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente

Info

Publication number
ATE456365T1
ATE456365T1 AT07831871T AT07831871T ATE456365T1 AT E456365 T1 ATE456365 T1 AT E456365T1 AT 07831871 T AT07831871 T AT 07831871T AT 07831871 T AT07831871 T AT 07831871T AT E456365 T1 ATE456365 T1 AT E456365T1
Authority
AT
Austria
Prior art keywords
dihydrobenzofuranyl
isoindoline
pharmaceutical composition
composition containing
lipophilic component
Prior art date
Application number
AT07831871T
Other languages
English (en)
Inventor
Satoshi Iinuma
Kazuhisa Kamikawa
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE456365T1 publication Critical patent/ATE456365T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07831871T 2006-11-09 2007-11-08 Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente ATE456365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006303800 2006-11-09
PCT/JP2007/072141 WO2008056822A1 (en) 2006-11-09 2007-11-08 Pharmaceutical composition comprising a dihydrobenzofuranyl isoindoline and a lipophilic component

Publications (1)

Publication Number Publication Date
ATE456365T1 true ATE456365T1 (de) 2010-02-15

Family

ID=38942774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07831871T ATE456365T1 (de) 2006-11-09 2007-11-08 Pharmazeutische zusammensetzung mit einem dihydrobenzofuranyl-isoindolin und einer lipophilen komponente

Country Status (11)

Country Link
US (1) US20100273852A1 (de)
EP (1) EP2079455B1 (de)
JP (1) JP2010509188A (de)
AR (1) AR063618A1 (de)
AT (1) ATE456365T1 (de)
CA (1) CA2668864A1 (de)
CL (1) CL2007003217A1 (de)
DE (1) DE602007004642D1 (de)
PE (1) PE20081491A1 (de)
TW (1) TW200833374A (de)
WO (1) WO2008056822A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113197851A (zh) 2015-05-06 2021-08-03 辛纳吉勒公司 包含药物粒子的药用悬浮液、用于其配给的装置、以及其使用方法
CN112020359A (zh) 2018-02-09 2020-12-01 分贝治疗公司 含有抗铂化学保护剂的高渗药物组合物
US10813947B1 (en) 2019-05-31 2020-10-27 Decibel Therapeutics, Inc. Methods of otoprotection against platinum-based antineoplastic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6479536B1 (en) * 1998-12-04 2002-11-12 Takeda Chemical Industries, Ltd. Benzofuran derivatives, process for the preparation of the same and uses thereof
KR20030009416A (ko) * 2000-04-04 2003-01-29 시오노기세이야쿠가부시키가이샤 고지용성 약물을 함유하는 유성 조성물
ES2312399T3 (es) * 2000-12-28 2009-03-01 Takeda Pharmaceutical Company Limited Procedimiento para preparar compuestos de 2,3-dihidrobenzofurano opticamente activos.
WO2003051355A1 (en) * 2001-12-19 2003-06-26 Takeda Chemical Industries, Ltd. Solid compositions containng compounds unstable to oxygen and method for stabilization thereof
WO2003074046A1 (en) * 2002-03-01 2003-09-12 Takeda Chemical Industries, Ltd. Antidepressant

Also Published As

Publication number Publication date
CA2668864A1 (en) 2008-05-15
EP2079455A1 (de) 2009-07-22
US20100273852A1 (en) 2010-10-28
DE602007004642D1 (de) 2010-03-18
WO2008056822A1 (en) 2008-05-15
PE20081491A1 (es) 2008-11-12
EP2079455B1 (de) 2010-01-27
TW200833374A (en) 2008-08-16
JP2010509188A (ja) 2010-03-25
CL2007003217A1 (es) 2008-07-04
AR063618A1 (es) 2009-02-04

Similar Documents

Publication Publication Date Title
ATE477794T1 (de) Pharmazeutische zusammensetzungen mit imatinib und einem freisetzungsverzögerer
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
EP2152237A4 (de) Neue pharmazeutische zusammensetzung
DE602007010797D1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
EP3861986C0 (de) Pharmazeutische zusammensetzungen mit polypeptiden und zugehörige abgabeverfahren
EP2037917A4 (de) Pharmazeutische zusammensetzung mit amlodipin und losartan
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
EP1984009A4 (de) Pharmazeutische zusammensetzungen mit verbesserter stabilität
ATE489850T1 (de) Pestizidzusammensetzung mit einem pyridylethylbenzamidderivat und insektizidverbindung
GB0413730D0 (en) A pharmaceutical composition and its use
ATE493119T1 (de) Pharmazeutische zusammensetzung
EP3124044C0 (de) Pharmazeutische zusammensetzungen mit clostridium difficile toxoiden a und b
GB0413729D0 (en) A pharmaceutical composition and its use
DK2399580T3 (da) Farmaceutiske doseringsformer
ZA200809998B (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto
ATE499089T1 (de) Pharmazeutische zusammensetzung in form von beschichteten mikrokügelchen zur modifizierten freisetzung eines muskelrelaxans und eines nsar
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
EP2193795A4 (de) Latanoprosthaltige wässrige pharmazeutische zusammensetzung
EP2341047A4 (de) Cyclohexanderivat und pharmazeutische anwendung davon
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
IL195639A0 (en) Tricyclic compound and pharmaceutical use thereof
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
ZA200803152B (en) Oramucosal pharmaceutical dosage form

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties